A Phase I study of RSR13, a radiation-enhancing hemoglobin modifier: Tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics
Brian D. Kavanagh, Shiv R. Khandelwal, Rupert K. Schmidt-Ullrich, John D. Roberts, Edward G. Shaw, Andrew D. Pearlman, Jurgen Venitz, Kathryn E. Dusenbery, Donald J. Abraham, Michael J. Gerber
Dive into the research topics of 'A Phase I study of RSR13, a radiation-enhancing hemoglobin modifier: Tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics'. Together they form a unique fingerprint.